Tissue Regenix Group Plc (TRX) — Net Asset Quality Index
Tissue Regenix Group Plc (TRX) has a Net Asset Quality Index of 60.7% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of GBX47.19 Million minus total liabilities of GBX18.56 Million yields net assets of GBX28.62 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check TRX financial resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Tissue Regenix Group Plc Net Asset Quality Index Over Time (2007–2024)
This chart shows how Tissue Regenix Group Plc's Net Asset Quality Index has evolved across 20 annual periods from 2007 to 2024. As of June 2025, the index stands at 60.7%, representing net assets of GBX28.62 Million against total assets of GBX47.19 Million GBX. See Tissue Regenix Group Plc (TRX) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Tissue Regenix Group Plc (2007–2024)
The table below presents the year-by-year Net Asset Quality Index for Tissue Regenix Group Plc from 2007 to 2024, covering 20 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see TRX market cap.
| Year | Quality Index | Net Assets (GBX) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 64.1% | GBX29.06 Million | GBX45.35 Million | GBX16.29 Million | ▼ -3.8 pp |
| 2023 | 67.9% | GBX29.36 Million | GBX43.24 Million | GBX13.89 Million | ▲ +1.9 pp |
| 2022 | 66.0% | GBX25.27 Million | GBX38.27 Million | GBX13.00 Million | ▼ -6.2 pp |
| 2021 | 72.2% | GBX24.65 Million | GBX34.13 Million | GBX9.47 Million | ▼ -3.6 pp |
| 2020 | 75.8% | GBX27.85 Million | GBX36.73 Million | GBX8.88 Million | ▼ -4.8 pp |
| 2019 | 80.7% | GBX24.59 Million | GBX30.50 Million | GBX5.90 Million | ▼ -5.8 pp |
| 2018 | 86.5% | GBX32.57 Million | GBX37.66 Million | GBX5.09 Million | ▲ +0.1 pp |
| 2018 | 86.4% | GBX39.52 Million | GBX45.76 Million | GBX6.24 Million | ▲ +0.0 pp |
| 2017 | 86.4% | GBX39.52 Million | GBX45.76 Million | GBX6.24 Million | ▲ +1.5 pp |
| 2016 | 84.8% | GBX11.54 Million | GBX13.60 Million | GBX2.06 Million | ▼ -6.7 pp |
| 2016 | 91.6% | GBX30.25 Million | GBX33.04 Million | GBX2.79 Million | ▲ +0.2 pp |
| 2015 | 91.4% | GBX11.58 Million | GBX12.67 Million | GBX1.09 Million | ▼ -3.1 pp |
| 2014 | 94.5% | GBX31.30 Million | GBX33.13 Million | GBX1.82 Million | ▼ -2.8 pp |
| 2013 | 97.3% | GBX38.64 Million | GBX39.73 Million | GBX1.08 Million | ▼ -0.4 pp |
| 2012 | 97.7% | GBX43.78 Million | GBX44.80 Million | GBX1.02 Million | ▲ +1.6 pp |
| 2011 | 96.1% | GBX9.84 Million | GBX10.24 Million | GBX400.37K | ▼ -2.5 pp |
| 2010 | 98.6% | GBX3.67 Million | GBX3.72 Million | GBX51.12K | ▲ +0.3 pp |
| 2009 | 98.4% | GBX3.63 Million | GBX3.70 Million | GBX60.53K | ▼ -0.8 pp |
| 2008 | 99.1% | GBX9.68 Million | GBX9.77 Million | GBX83.52K | ▼ -0.6 pp |
| 2007 | 99.7% | GBX5.74 Million | GBX5.75 Million | GBX15.69K | — |